SwePub
Sök i SwePub databas

  Utökad sökning

Träfflista för sökning "L773:0896 8411 OR L773:1095 9157 "

Sökning: L773:0896 8411 OR L773:1095 9157

  • Resultat 121-130 av 149
Sortera/gruppera träfflistan
   
NumreringReferensOmslagsbildHitta
121.
  •  
122.
  •  
123.
  • Lu, Shemin, et al. (författare)
  • Immunization of Rats with Homologous Type XI Collagen Leads to Chronic and Relapsing Arthritis with Different Genetics and Joint Pathology Than Arthritis Induced with Homologous Type II Collagen.
  • 2002
  • Ingår i: Journal of Autoimmunity. - : Elsevier BV. - 0896-8411. ; 18:3, s. 199-211
  • Tidskriftsartikel (refereegranskat)abstract
    • The most commonly used animal model for rheumatoid arthritis (RA) is collagen-induced arthritis (CIA), induced by immunization with type II collagen (CII), a cartilage restricted protein. In this work we show that type XI collagen (CXI), which is a minor component in cartilage, induces a different form of erosive and chronic relapsing polyarthritis in rats. Using a series of inbred rat strains involving various genetic backgrounds (DA, LEW, E3), and congenic MHC regions (a, u, f, n, c, d), we found that CXI induced arthritis (C(XI)IA) is associated with the RT1f haplotype in contrast to CII induced arthritis (C(II)IA), which is associated with the RT1a and RT1u haplotypes. The C(XI)IA follows a chronic disease course affecting peripheral joints with both progression and relapses, which appear not to cease (occurring >800 days). Susceptible strains showed a sustained antibody response to CXI with time indicating that the autoimmune response was self-perpetuated. Microscopic analysis of the joints at different stages demonstrated the severe destruction of bone and cartilage by pannus tissue consisting of activated macrophages and T cells. The main difference to joints from rats with C(II)IA was larger numbers of infiltrating lymphocytes and these tended to form follicle-like aggregates. Surprisingly, males were more susceptible to C(XI)IA than females whereas the opposite has been observed in other rat arthritis models, including C(II)IA. Taken together, C(XI)IA is a chronic relapsing and erosive polyarthritis that is MHC associated, which in fact fulfills the criteria for diagnosis of RA. Thus the C(XI)IA model will be useful as a novel and relevant animal model for RA.
  •  
124.
  •  
125.
  • Lynch, Kristian F., et al. (författare)
  • Gestational respiratory infections interacting with offspring HLA and CTLA-4 modifies incident β-cell autoantibodies
  • 2018
  • Ingår i: Journal of Autoimmunity. - : Elsevier BV. - 0896-8411. ; 86, s. 93-103
  • Tidskriftsartikel (refereegranskat)abstract
    • β-cell autoantibodies against insulin (IAA), GAD65 (GADA) and IA-2 (IA-2A) precede onset of childhood type 1 diabetes (T1D). Incidence of the first appearing β-cell autoantibodies peaks at a young age and is patterned by T1D-associated genes, suggesting an early environmental influence. Here, we tested if gestational infections and interactions with child's human leukocyte antigen (HLA) and non-HLA genes affected the appearance of the first β-cell autoantibody. Singletons of mothers without diabetes (n = 7472) with T1D-associated HLA-DR-DQ genotypes were prospectively followed quarterly through the first 4 years of life, then semiannually until age 6 years, using standardized autoantibody analyses. Maternal infections during pregnancy were assessed via questionnaire 3-4.5 months post-delivery. Polymorphisms in twelve non-HLA genes associated with the first appearing β-cell autoantibodies were included in a Cox regression analysis. IAA predominated as the first appearing β-cell autoantibody in younger children (n = 226, median age at seroconversion 1.8 years) and GADA (n = 212; 3.2 years) in children aged ≥2 years. Gestational infections were not associated with the first appearing β-cell autoantibodies overall. However, gestational respiratory infections (G-RI) showed a consistent protective influence on IAA (HR 0.64, 95% CI 0.45-0.91) among CTLA4-(AG, GG) children (G-RI*. CTLA4 interaction, p = 0.002). The predominant associations of HLA-DR-DQ 4-8/8-4 with IAA and HLA-DR-DQ 3-2/3-2 with GADA were not observed if a G-RI was reported (G-RI*HLA-DR-DQ interaction, p = 0.03). The role of G-RI may depend on offspring HLA and CTLA-4 alleles and supports a bidirectional trigger for IAA or GADA as a first appearing β-cell autoantibody in early life.
  •  
126.
  • Magnusson, Yvonne, 1957, et al. (författare)
  • Functional analysis of rabbit anti-peptide antibodies which mimic autoantibodies against the beta 1-adrenergic receptor in patients with idiopathic dilated cardiomyopathy.
  • 1991
  • Ingår i: Journal of autoimmunity. - 0896-8411. ; 4:6, s. 893-905
  • Tidskriftsartikel (refereegranskat)abstract
    • A synthetic peptide corresponding to the second extracellular loop of the beta 1-adrenergic receptor was used as an antigen for antibody production in three rabbits. Antibodies of high titers were obtained in all rabbits. Only one rabbit yielded antibodies which decreased radioligand binding on the receptor in a similar way to that described for autoantibodies in patients with dilated cardiomyopathy. These antibodies recognized the receptor protein in immunoblots. Epitope mapping indicated that the N-terminal sequence of the loop used as antigen was the target of the major antigen fraction. Incubation of antibodies with C6 glioma cell membranes or inner membranes of E. coli, which express the human beta 1-adrenergic receptor, resulted in a decrease in number of radioligand binding sites. This decrease was dependent on the concentration of antibody and of Mg++ ions. It was not affected by the GTP analog GppNHp or the beta 1 subtype-specific antagonist metoprolol. The agonist, isoproterenol, also induced a decrease but the effects of antibody and agonist were not additive. These results suggest that the antibodies induce a Mg(++)-dependent, 'active', labile conformation of the receptor, independent from coupling to the GTP regulatory protein, but similar to that induced by the agonist isoproterenol. This interpretation was corroborated by the beta 1-adrenergic receptor agonist-like effect of the antibodies on cardiomyocytes in culture.
  •  
127.
  • Maverakis, Emanual, et al. (författare)
  • International consensus criteria for the diagnosis of Raynaud's phenomenon.
  • 2014
  • Ingår i: Journal of Autoimmunity. - : Elsevier BV. - 0896-8411. ; 48-49:Jan 31, s. 60-65
  • Tidskriftsartikel (refereegranskat)abstract
    • Vasoconstriction accompanied by changes in skin color is a normal physiologic response to cold. The distinction between this normal physiology and Raynaud's phenomenon (RP) has yet to be well characterized. In anticipation of the 9th International Congress on Autoimmunity, a panel of 12 RP experts from 9 different institutes and four different countries were assembled for a Delphi exercise to establish new diagnostic criteria for RP. Relevant investigators with highly cited manuscripts in Raynaud's-related research were identified using the Web of Science and invited to participate. Surveys at each stage were administered to participants via the on-line SurveyMonkey software tool. The participants evaluated the level of appropriateness of statements using a scale of 1 (extremely inappropriate) through 9 (extremely appropriate). In the second stage, panel participants were asked to rank rewritten items from the first round that were scored as "uncertain" for the diagnosis of RP, items with significant disagreement (Disagreement Index > 1), and new items suggested by the panel. Results were analyzed using the Interpercentile Range Adjusted for Symmetry (IPRAS) method. A 3-Step Approach to diagnose RP was then developed using items the panelists "agreed" were "appropriate" diagnostic criteria. In the final stage, the panel was presented with the newly developed diagnostic criteria and asked to rate them against previous models. Following the first two iterations of the Delphi exercise, the panel of 12 experts agreed that 36 of the items were "appropriate", 12 items had "uncertain" appropriateness, and 13 items were "inappropriate" to use in the diagnostic criteria of RP. Using an expert committee, we developed a 3-Step Approach for the diagnosis of RP and 5 additional criteria for the diagnosis of primary RP. The committee came to an agreement that the proposed criteria were "appropriate and accurate" for use by physicians to diagnose patients with RP.
  •  
128.
  • Mobini, Reza, 1965, et al. (författare)
  • Hemodynamic improvement and removal of autoantibodies against beta1-adrenergic receptor by immunoadsorption therapy in dilated cardiomyopathy.
  • 2003
  • Ingår i: Journal of autoimmunity. - 0896-8411. ; 20:4, s. 345-50
  • Tidskriftsartikel (refereegranskat)abstract
    • The removal of beta(1)-adrenergic receptor (beta(1)AR) autoantibodies by immunoadsorption (IA) has been proposed as a potential mechanism for the improvement of the left ventricular function in dilated cardiomyopathy (DCM). In the present study, the possible association between removal of the autoantibodies against the human beta(1)AR with the hemodynamic improvement induced by IA was investigated.IA was performed in 22 DCM patients (n=22; NYHA III-IV, EF<30%, stable medication). The beta(1)AR autoantibodies from column eluents (CE) were detected by enzyme-linked immunosorbent assay (ELISA) and BIAcore methods. CE of 32% (7/22) of the patients was found to be antibody-positive with ELISA or BIAcore. In addition, a bioassay system was also used for the detection of this autoantibody. Seventy-three percent (16/22) of the patients were found to be antibody-positive by this method. However, independent of the beta(1)AR antibody detection method, both antibody-positive and antibody-negative groups showed similar acute and prolonged hemodynamic improvements during IA therapy. Furthermore, antibody-positive and -negative groups received a comparable improvement of left ventricular ejection fraction.These results suggest that different mechanisms are involved in the hemodynamic improvement induced by IA. The beneficial hemodynamic effects induced by IA are not directly associated with the removal of beta(1)AR autoantibodies.
  •  
129.
  • Mobini, Reza, 1965, et al. (författare)
  • Probing the immunological properties of the extracellular domains of the human beta(1)-adrenoceptor.
  • 1999
  • Ingår i: Journal of autoimmunity. - : Elsevier BV. - 0896-8411. ; 13:2, s. 179-86
  • Tidskriftsartikel (refereegranskat)abstract
    • The human beta(1)-adrenoceptor is an immune target for autoantibodies with functional activity in cardiovascular diseases. Different epitopes on the extracellular domains of the receptor are involved. To study the immunological and pharmacological properties of these epitopes, rabbits were immunized with peptides corresponding to a large domain in the N-terminal part of the receptor and to its first and second extracellular loops. In contrast to the two other peptides, the first extracellular loop did not have immunogenic properties but acted as a hapten. Antibodies affinity-purified with the three synthetic peptides were able to significantly immunoprecipitate the solubilized receptor, confirming that they recognized the target receptor. While antibodies against the N-terminal domain did not inhibit the binding of a radiolabelled antagonist to the receptor, those against the first and second extracellular loop showed non-competitive inhibition. Similarly, only the two latter antibodies exerted a specific agonist-like effect on the receptor, as assessed on neonatal rat cardiomyocytes in culture. Our results are in accordance with those found for human anti-receptor autoantibodies with functional effects. We conclude that not all extracellular epitopes give rise to functional autoantibodies with potential physiopathological relevance in cardiac diseases with an autoimmune component.
  •  
130.
  •  
Skapa referenser, mejla, bekava och länka
  • Resultat 121-130 av 149
Typ av publikation
tidskriftsartikel (145)
forskningsöversikt (4)
Typ av innehåll
refereegranskat (145)
övrigt vetenskapligt/konstnärligt (3)
populärvet., debatt m.m. (1)
Författare/redaktör
Link, H (6)
Alarcon-Riquelme, ME (6)
KLARESKOG, L (4)
Gronwall, C. (4)
Sturfelt, Gunnar (4)
Malmstrom, V (4)
visa fler...
LERNMARK, A (4)
Lundberg, IE (4)
Lernmark, Åke (4)
Singh, K. (3)
Olsson, T (3)
Bengtsson, Anders (3)
Sundquist, Kristina (3)
Truedsson, Lennart (3)
Alarcón-Riquelme, Ma ... (3)
Byrareddy, SN (3)
Rönnblom, Lars (3)
Cilio, Corrado M (3)
Dastmalchi, M (3)
Zhu, J. (2)
Liu, S. (2)
Mix, E (2)
Khademi, M. (2)
Berg, L (2)
Andersson, J (2)
Ernerudh, Jan (2)
Gunnarsson, Iva (2)
Svenungsson, Elisabe ... (2)
Jönsen, Andreas (2)
Steinsson, Kristjan (2)
Engstrom, M (2)
Wollheim, Frank (2)
Kämpe, Olle (2)
Tandre, Karolina (2)
Lorson, CL (2)
FALORNI, A (2)
Beretta, L (2)
Alfredsson, L (2)
Nilsson Ekdahl, Kris ... (2)
Nilsson, Bo (2)
Bokarewa, Maria, 196 ... (2)
Theander, Elke (2)
Bae, Sang-Cheol (2)
Ramsey-Goldman, Rosa ... (2)
Kamen, Diane L. (2)
Klareskog, Lars (2)
Catrina, AI (2)
Réthi, B (2)
Villablanca, EJ (2)
Triplett, Eric W. (2)
visa färre...
Lärosäte
Karolinska Institutet (88)
Lunds universitet (26)
Uppsala universitet (24)
Linköpings universitet (20)
Umeå universitet (14)
Göteborgs universitet (10)
visa fler...
Örebro universitet (3)
Jönköping University (2)
Linnéuniversitetet (2)
Kungliga Tekniska Högskolan (1)
Högskolan i Halmstad (1)
Stockholms universitet (1)
visa färre...
Språk
Engelska (149)
Forskningsämne (UKÄ/SCB)
Medicin och hälsovetenskap (58)
Naturvetenskap (7)
Samhällsvetenskap (1)

År

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy